News
Philips' Chief Executive Gerard Kleisterlee officially hands over the reins to Frans van Houten later this week, and as he does so one could forgive him for looking with a twinge of regret at the ...
The Siemens approval for its Mammomat Inspiration with Tomosynthesis Option is the latest advance for the 3-D imaging technology. In 2011, breast tomosynthesis kicked off with an approval for Hologic.
"Siemens is proud to announce the availability of 3-D-only screening with our Mammomat Inspiration with Tomosynthesis Option digital mammography system," said Martin Silverman, VP of X-ray ...
NEW YORK, Nov. 17, 2010 /PRNewswire/ -- It's a daunting, nerve-wracking and sometimes painful annual exam, but with 1 in 8 women likely to be diagnosed with cancer during her lifetime ...
Siemens’ breast tomosynthesis option is available on the company’s MAMMOMAT Inspiration and MAMMOMAT Inspiration Prime Edition digital mammography systems. Published On Apr 26, 2015 at 12:56 ...
Siemens Healthineers has gained premarket approval (PMA) from the US Food and Drug Administration (FDA) for 3D technology in its Mammomat B.brilliant mammography system. The PMA covers ...
At the annual event of Indonesian Women Imaging Society, Siemens Healthineers has unveiled the MAMMOMAT B.brilliant, a groundbreaking mammography system designed to transform breast imaging in ...
Mammomat Revelation with integrated specimen imaging tool As soon as the tissue sample has been taken, it has to be X-rayed to confirm that the biopsy was successful. In current settings, samples have ...
Contacts Contact for journalists: Siemens Healthcare Jeff Bell, +1 610-448-1477 jeffrey.t.bell@siemens.com ...
Siemens Healthineers unveils MAMMOMAT B.brilliant, a revolutionary mammography system in Indonesia PR Newswire May. 2, 2025 16:08 379 ...
SURABAYA, Indonesia, May 2, 2025 /PRNewswire/ -- Breast cancer remains one of the leading health concerns in Indonesia and ranks as the third deadliest cancer after lung and liver cancer. According to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results